Abstract
Oncological therapy approaches are measured by hard outcome parameters like survival time, quality of life or at best by the relation of survival time and quality of life (health adjusted life years or quality adjusted life years). Surrogate markers like response under therapy (complete remission, partial remission) or time to progression and laboratory parameters turn out to be invalid therapy aims.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
